R, H., AM, W., & JN, C. (2019). Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: Evidence to date. Dove Medical Press.
Style de citation Chicago (17e éd.)R, Howell, Wright AM, et Clements JN. Clinical Potential of Liraglutide in Cardiovascular Risk Reduction in Patients with Type 2 Diabetes: Evidence to Date. Dove Medical Press, 2019.
Style de citation MLA (8e éd.)R, Howell, et al. Clinical Potential of Liraglutide in Cardiovascular Risk Reduction in Patients with Type 2 Diabetes: Evidence to Date. Dove Medical Press, 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.